Back

BioChemAIgent: An AI-driven Protein Modeling and Docking Framework for Structure-Based Drug Discovery

Yousefi, B.; Laubach, N. C.; Heins, S.; Testa, L.; Gersting, S. W.; Bonn, S.

2025-12-19 bioinformatics
10.64898/2025.12.17.694892 bioRxiv
Show abstract

Recent advances in AI have substantially accelerated in silico drug discovery, yet most computational approaches remain task-specific and require expert knowledge. We present BioChemAIgent, an agentic framework that orchestrates state-of-the-art AI models and established computational chemistry tools to support end-to-end small-molecule analysis, protein modeling, molecular docking, and interaction analysis through a unified interface. BioChemAIgent emphasizes transparent reasoning, reproducible workflows, and community-oriented extensibility for structural biology and drug discovery applications.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.